Cargando…
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen
PURPOSE: High-risk lesions (HRLs) of the breast are an indication for chemoprevention, yet uptake is low, largely due to concerns about side effects. In 2019, low-dose (5 mg) tamoxifen was demonstrated to reduce breast cancer risk with improved tolerance. We describe chemoprevention uptake in an aca...
Autores principales: | Bychkovsky, Brittany, Laws, Alison, Katlin, Fisher, Hans, Marybeth, Knust Graichen, Mary, Pace, Lydia E., Scheib, Rochelle, Garber, Judy E., King, Tari A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978759/ https://www.ncbi.nlm.nih.gov/pubmed/35378642 http://dx.doi.org/10.1007/s10549-022-06577-5 |
Ejemplares similares
-
Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study
por: King, Claire B., et al.
Publicado: (2023) -
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023) -
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023) -
Chemoprevention: beyond tamoxifen
por: Cuzick, J
Publicado: (2005) -
Breast cancer chemoprevention: beyond tamoxifen
por: Fabian, Carol J
Publicado: (2001)